Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Safety and Effectiveness of Cortical Stimulation in the Treatment of Stroke Patients With Upper Extremity Hemiparesis (EVEREST)
This study is ongoing, but not recruiting participants.
Sponsored by: Northstar Neuroscience
Information provided by: Northstar Neuroscience
ClinicalTrials.gov Identifier: NCT00170716
  Purpose

The purpose of this study is to assess the safety and effectiveness of cortical stimulation delivered concurrent with rehabilitation activities to enhance motor recovery in patients suffering from hemiparesis affecting the upper extremity following a stroke.


Condition Intervention Phase
Stroke
Hemiparesis
Device: Cortical Stimulation and rehabilitation
Other: Rehabilitation
Phase III

MedlinePlus related topics: Rehabilitation
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind (Outcomes Assessor), Parallel Assignment, Safety/Efficacy Study
Official Title: Safety and Effectiveness of Targeted Sub-Threshold Epidural Cortical Stimulation Delivered Concurrent With Rehabilitation Activities to Enhance Motor Recovery in Patients Suffering From Upper Extremity Hemiparesis Following a Stroke

Further study details as provided by Northstar Neuroscience:

Primary Outcome Measures:
  • Arm Motor Fugl-Meyer (AMFM) score [ Time Frame: Follow Up Week 4 ] [ Designated as safety issue: No ]
  • Arm Motor Ability Test (AMAT) score [ Time Frame: Follow Up Week 4 ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Box and Block Test score [ Time Frame: Follow Up Week 4 ] [ Designated as safety issue: No ]
  • Stroke Specific Quality of Life (SSQOL) score [ Time Frame: Follow Up Week 4 ] [ Designated as safety issue: No ]
  • Serious adverse event rate [ Time Frame: Follow up week 4 and 6 months ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 174
Study Start Date: September 2004
Estimated Study Completion Date: March 2008
Arms Assigned Interventions
Control: Active Comparator Other: Rehabilitation
Rehabilitation is for 2.5 hrs per day for 26 days over a period of 6 weeks.
Investigational: Experimental Device: Cortical Stimulation and rehabilitation
Cortical stimulation is provided concomitantly with rehabilitation therapy. Rehabilitation is for 2.5 hrs per day for 26 days over a period of 6 weeks.

Detailed Description:

Stroke is a leading cause of serious, long-term disability in the United States. According to the American Stroke Association, the prevalence of stroke in the U.S. is approximately 4.8 million with approximately 700,000 additional strokes occurring annually. The 2001 overall death rate for stroke was 58%. Of those who survive, 30 to 50 percent do not regain functional independence, 15 to 30 percent are permanently disabled, and 20% require institutional care at three months after onset.

The most common neurological deficit among these stroke survivors, and thus a substantial contributor to post-stroke disability, is a motor weakness on one (hemiparesis) side of the body. Presently, the only treatment available for patients with motor deficits is rehabilitative therapy. However, many patients are not responsive to standard rehabilitative therapy or achieve a less than satisfactory improvement in function.

The primary objective of this study is to determine the safety and effectiveness of targeted sub-threshold epidural cortical stimulation delivered concurrent with rehabilitation activities to enhance motor recovery in patients suffering from hemiparesis (a motor weakness in one half of the body) affecting the upper extremity (shoulder, arm, wrist, hand) following a stroke. In addition to evaluating changes from baseline level, safety and efficacy measures will be compared to patients who undergo the same rehabilitation activities but without cortical stimulation. The two study groups will be compared to determine the degree to which motor function of the affected limb can be improved beyond rehabilitation alone by epidural stimulation of a targeted cortical region.

  Eligibility

Ages Eligible for Study:   21 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Subjects must have an ischemic stroke.
  • Moderate to moderately severe upper-extremity hemiparesis.
  • Aged 21 years or older.

Exclusion Criteria:

  • Primary hemorrhagic stroke.
  • Any additional stroke associated with incomplete motor recovery.
  • Any neurologic or physical condition impairing function of the target extremity.
  • History of seizure disorder.
  • History of spinal cord injury, traumatic brain injury, or spontaneous subdural or epidural hematoma that has resulted in a neurologic deficit.
  • Contraindication to magnetic resonance (MR) imaging.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00170716

  Show 21 Study Locations
Sponsors and Collaborators
Northstar Neuroscience
  More Information

Related Info  This link exits the ClinicalTrials.gov site
Related Info  This link exits the ClinicalTrials.gov site

Publications:
Responsible Party: Northstar Neuroscience ( VP Clinical Affairs )
Study ID Numbers: V0267
Study First Received: September 9, 2005
Last Updated: December 18, 2007
ClinicalTrials.gov Identifier: NCT00170716  
Health Authority: United States: Food and Drug Administration

Keywords provided by Northstar Neuroscience:
Motor Cortex Electrical Stimulation
Ischemic Stroke
Upper Extremity Hemiparesis
Rehabilitation
Motor Recovery
Functional MRI

Study placed in the following topic categories:
Paresis
Cerebral Infarction
Stroke
Vascular Diseases
Central Nervous System Diseases
Ischemia
Brain Diseases
Cerebrovascular Disorders
Signs and Symptoms
Neurologic Manifestations
Brain Ischemia
Brain Infarction
Infarction

Additional relevant MeSH terms:
Nervous System Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009